Precision Medicine
The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision medicine means moving healthcare from a one-size-fits-all approach to a more targeted approach, where decisions are informed by each individual’s unique clinical, molecular, and lifestyle information. Working closely together with the precision medicine community, Thermo Fisher Scientific is helping advance this revolution in diagnosis and treatment. We leverage our global infrastructure and expertise to provide industry-leading capabilities, from population stratification to targeted therapeutics.
Explore our scalable population-level
molecular profiling solutions designed
to deliver rapid clinical utility.
Pioneer the path from discovery to the clinic with proven platforms and cutting-edge technologies.
Discover flexible solutions for the rapid development and implementation of clinical assays.
Accelerate targeted therapeutic and
companion diagnostic development
and commercialization with our
comprehensive solutions.
Featured stories
Leaders gather for first China-United States Precision Medicine Summit
Both the U.S. and China are committed to accelerating the adoption of precision medicine globally, and came together to host the first China-U.S. Precision Medicine Summit. More than 400 leaders from across government, academia, and industry convened to establish a collaborative ecosystem aimed at advancing the prevention, diagnosis, and treatment of disease.
Cancer patient finds hope and remission in CAR T-cell therapy
Cancer patient Nicole Gularte was on hospice with only three to five weeks to live. Test results showed that she qualified for a new CAR T-cell therapy clinical trial. Learn more about this new therapy and what it means for the future of cancer treatment.
Practicing Pharmacogenomics at Scale
Pharmacogenomics (PGx) envisions the widespread use of genetic testing to predict how patients may respond to particular medications, and is increasingly used during drug discovery and development. Learn about the new PGx Center of Excellence at the University of Pittsburgh, and its efforts to demonstrate the value of pre-emptive PGx testing in routine clinical care.
- Thermo Fisher Scientific Expands Oncomine Immuno-Oncology Asssay Portfolio
- Thermo Fisher Scientific Opens U.S. Precision Medicine Science Center
- International Childhood Oncology Network to Host Inaugural Meeting at Annual ASCO Conference
- Thermo Fisher Scientific Installs First Glacios Cryo-Electron Microscope for Drug Discovery and Development
- Thermo Fisher Scientific Signs New Agreements to Expand Oncomine Dx Target Test
- Thermo Fisher Scientific Announces $50 Million Investment to Enhance Biologics Capabilities
- Thermo Fisher Scientific Launches Oncomine Childhood Cancer Research Assay and Establishes International Childhood Oncology Network
- What is Immuno-Oncology?
- Non-Small Cell Lung Cancer Survivor Becomes High-Profile Advocate for ROS1 Testing
- Genetic Analysis Tools Help Doctors Design a Life-Saving Clinical Trial for Child with End-Stage Brain Cancer
- Collaboration is Key as NGS-Based Precision Medicine Begins to Impact Pediatric Oncology
- Capitol Hill Briefing Sheds Light on Advancements and Hurdles Surrounding Molecular Diagnostics
- A Huge Step Forward for Immunotherapy: FIRST ever FDA approved CAR-T cell therapy
- Aiming High in the Fight to End Cancer
- Thermo Fisher Scientific Expands Oncomine Immuno-Oncology Asssay Portfolio
- Thermo Fisher Scientific Opens U.S. Precision Medicine Science Center
- International Childhood Oncology Network to Host Inaugural Meeting at Annual ASCO Conference
- Thermo Fisher Scientific Installs First Glacios Cryo-Electron Microscope for Drug Discovery and Development
- Thermo Fisher Scientific Signs New Agreements to Expand Oncomine Dx Target Test
- Thermo Fisher Scientific Announces $50 Million Investment to Enhance Biologics Capabilities
- Thermo Fisher Scientific Launches Oncomine Childhood Cancer Research Assay and Establishes International Childhood Oncology Network
- What is Immuno-Oncology?
- Non-Small Cell Lung Cancer Survivor Becomes High-Profile Advocate for ROS1 Testing
- Genetic Analysis Tools Help Doctors Design a Life-Saving Clinical Trial for Child with End-Stage Brain Cancer
- Collaboration is Key as NGS-Based Precision Medicine Begins to Impact Pediatric Oncology
- Capitol Hill Briefing Sheds Light on Advancements and Hurdles Surrounding Molecular Diagnostics
- A Huge Step Forward for Immunotherapy: FIRST ever FDA approved CAR-T cell therapy
- Aiming High in the Fight to End Cancer